Mie Afify
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mie Afify has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Weaam Gouda
Biochemistry Department, Biotechnology Research Institute, National Research Centre, Giza, Egypt
4 shared publications - Esmat Ashour
Biochemistry Department, National Research Centre, Giza, Egypt
3 shared publications - Lamiaa Mageed
Biochemistry Department, National Research Centre, Giza, Egypt
3 shared publications Nervana Samy
Biochemistry Department, NRC
3 shared publicationsWeaam Gouda
Biochemistry Department, National Research Centre, Giza, Egypt
3 shared publicationsEsmat Wahba
Biochemistry Department, National Research Centre (NRC), Giza-Egypt
2 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by Hamad bin Khalifa University Press (HBKU Press) in Qatar Medical Journal
- Vol. 2024 (4) , 71
Evaluation of the association of some circulating miRNA molecules in the metabolic syndrome
Purpose: The aim of this study was to investigate the possibility of including miRNA-371 and miRNA-143 in the early detection and diagnosis of the extent of the metabolic syndrome (MetS) in obese patients by measuring the expression of miRNA-143 and miRNA-371 in metabolically and pre-metabolically obese individuals and comparing the results with metabolically healthy obese controls. In addition, the study aimed to assess the correlation between the two types of miRNA and the criteria of MetS. Methods: The expression levels of miRNA-143 and miRNA-371 were determined using quantitative real-time polymerase chain reaction (PCR) for 135 obese patients who were divided into the following three different categories based on metabolic criteria: 1) metabolic syndrome obese (MetS) group, 2) pre-metabolic syndrome obese (PreMetS) group, and 3) metabolically healthy obese (MHO) group. Results: The results indicated a significant association of miRNA-143 and miRNA-371 with the MetS group compared with the PreMetS and MHO groups. As a result, the correlation analysis for these miRNAs revealed a large association with the results of the analysis for various factors, especially with regard to fasting glucose and lipid profiles in the MetS group. Conclusion: There was an association between obesity and MetS. This study was able to establish the role of miRNA-371 and miRNA-143 molecules in metabolically obese individuals. Therefore, by tracking the regulatory pathway of these molecules and expanding the understanding of the process of regulation and interference with the various metabolic pathways, this study could provide a deeper analysis and understanding of the MetS in obesity and the molecular causes leading to it.
- 1 January 2025
- Published by Hamad bin Khalifa University Press (HBKU Press) in Qatar Medical Journal
- Vol. 2024 (4) , 71
Open AccessEvaluation of the association of some circulating miRNA molecules in the metabolic syndrome
Purpose: The aim of this study was to investigate the possibility of including miRNA-371 and miRNA-143 in the early detection and diagnosis of the extent of the metabolic syndrome (MetS) in obese patients by measuring the expression of miRNA-143 and miRNA-371 in metabolically and pre-metabolically obese individuals and comparing the results with metabolically healthy obese controls. In addition, the study aimed to assess the correlation between the two types of miRNA and the criteria of MetS. Methods: The expression levels of miRNA-143 and miRNA-371 were determined using quantitative real-time polymerase chain reaction (PCR) for 135 obese patients who were divided into the following three different categories based on metabolic criteria: 1) metabolic syndrome obese (MetS) group, 2) pre-metabolic syndrome obese (PreMetS) group, and 3) metabolically healthy obese (MHO) group. Results: The results indicated a significant association of miRNA-143 and miRNA-371 with the MetS group compared with the PreMetS and MHO groups. As a result, the correlation analysis for these miRNAs revealed a large association with the results of the analysis for various factors, especially with regard to fasting glucose and lipid profiles in the MetS group. Conclusion: There was an association between obesity and MetS. This study was able to establish the role of miRNA-371 and miRNA-143 molecules in metabolically obese individuals. Therefore, by tracking the regulatory pathway of these molecules and expanding the understanding of the process of regulation and interference with the various metabolic pathways, this study could provide a deeper analysis and understanding of the MetS in obesity and the molecular causes leading to it.
- Open Access
- 10 March 2022
- Published by Springer Nature in Egyptian Journal of Medical Human Genetics
- Vol. 23 (1) , 1-10
Association of gene polymorphisms of ACE, AGT, and ARNT-like protein 1 with susceptibility to gestational diabetes
Background and aims: Gestational diabetes mellitus is well-defined as glucose intolerance first documented during pregnancy. In this study, we examined the possible associations between I/D polymorphism of the angiotensin-converting enzyme gene, the M235T variant of angiotensinogen gene, and the rs7950226 polymorphism of the ARNT-like protein-1 (BMAL1) gene and the risk for diabetes in Egyptian pregnant women. Subjects and methods: This study recruited 160 gestational diabetes cases and 165 controls. Genomic DNA was derived from peripheral blood leukocytes and ACE gene (I/D) genotyping was performed using the method of polymerase chain reaction and the polymerase chain reaction-based restriction fragment length polymorphism was used for identifying the M235T variant of AGT gene and the rs7950226 polymorphism of the BMAL1. Results: The II, ID, and DD genotypes of the ACE gene have significant differences in cases compared to controls (P = 0.000 and X2 = 81.77). The M235T polymorphism of the AGT gene was increased with gestational diabetes risk. Furthermore, the AA genotype of the BMAL1 rs7950226 gene was significantly related to the gestational diabetes risk (P = 0.000 and X2 = 52.82). Furthermore, the allele frequencies of the three variants have significant variances between cases and control. Conclusion: This study suggested significant associations between ACE (DD), AGT (TT), and BMAL1 rs7950226 (AA) gene polymorphisms with gestational diabetes susceptibility and there was a possibility to identify that II + MM + GG as protective haplotypes and DD + TT + AA as risk haplotypes for gestational diabetes.
- 10 March 2022
- Published by Springer Nature in Egyptian Journal of Medical Human Genetics
- Vol. 23 (1) , 1-10
Open AccessAssociation of gene polymorphisms of ACE, AGT, and ARNT-like protein 1 with susceptibility to gestational diabetes
Background and aims: Gestational diabetes mellitus is well-defined as glucose intolerance first documented during pregnancy. In this study, we examined the possible associations between I/D polymorphism of the angiotensin-converting enzyme gene, the M235T variant of angiotensinogen gene, and the rs7950226 polymorphism of the ARNT-like protein-1 (BMAL1) gene and the risk for diabetes in Egyptian pregnant women. Subjects and methods: This study recruited 160 gestational diabetes cases and 165 controls. Genomic DNA was derived from peripheral blood leukocytes and ACE gene (I/D) genotyping was performed using the method of polymerase chain reaction and the polymerase chain reaction-based restriction fragment length polymorphism was used for identifying the M235T variant of AGT gene and the rs7950226 polymorphism of the BMAL1. Results: The II, ID, and DD genotypes of the ACE gene have significant differences in cases compared to controls (P = 0.000 and X2 = 81.77). The M235T polymorphism of the AGT gene was increased with gestational diabetes risk. Furthermore, the AA genotype of the BMAL1 rs7950226 gene was significantly related to the gestational diabetes risk (P = 0.000 and X2 = 52.82). Furthermore, the allele frequencies of the three variants have significant variances between cases and control. Conclusion: This study suggested significant associations between ACE (DD), AGT (TT), and BMAL1 rs7950226 (AA) gene polymorphisms with gestational diabetes susceptibility and there was a possibility to identify that II + MM + GG as protective haplotypes and DD + TT + AA as risk haplotypes for gestational diabetes.
- 1 December 2020
- Published by Egyptian Knowledge Bank in Egyptian Journal of Chemistry
- Vol. 63 (12) , 9-10
Modafinil Alleviates Rotenone-Induced Neurochemical changes and Striatal Neurodegeneration via Inhibiting Oxidative Stress and Neuroinflammation
Objectives of study are around investigation the effect of the central nervous system stimulant modafinil on brain striatum neurodegeneration caused by subcutaneous (s.c.) rotenone administration in rats, further, the possible modulation by modafinil on L-dopa effect on oxidative stress, inflammation and nigrostriatal cell damage. Seven groups of Male albino mice received dimethyl sulfoxides.c., rotenone (1.5 mg/kg, s.c., 3 times per week), rotenone/L-dopa (25 mg/kg, p.o., daily), rotenone/modafinil (0.1, 0.2 and 0.3 mg/kg respectively, p.o., daily), rotenone/L-dopa/modafinil (0.2 mg/kg, p.o. daily). The treatment was continued for 2 weeks. Mice were tested for behavioral changes 24h after the end of treatments.Mice were evaluated for brain biochemical markers of oxidative stress (lipid peroxidation, reduced glutathione, and nitric oxide), pro-inflammatory factors (tumor necrosis factor-α, interlukin-1beta) and dopamine level. Histopathologic examination and the expression of the anti-apoptotic protein caspase-3 were also performed. Rotenone significantly elevated oxidative stress and pro-inflammation, decreased dopamine, induced substantianigra damage with caspase-3-mediated apoptosis respectly to the control levels. Results of modafinil or its combination with L-dopa may have potential therapeutic effect in Parkinson’s disease by decreasing pro-inflammation and oxidative stress, increasing dopamine, preventing the development of neuronal damage and reducing caspase-3 expression in the striatum.
- 1 December 2020
- Published by Egyptian Knowledge Bank in Egyptian Journal of Chemistry
- Vol. 63 (12) , 9-10
Modafinil Alleviates Rotenone-Induced Neurochemical changes and Striatal Neurodegeneration via Inhibiting Oxidative Stress and Neuroinflammation
Objectives of study are around investigation the effect of the central nervous system stimulant modafinil on brain striatum neurodegeneration caused by subcutaneous (s.c.) rotenone administration in rats, further, the possible modulation by modafinil on L-dopa effect on oxidative stress, inflammation and nigrostriatal cell damage. Seven groups of Male albino mice received dimethyl sulfoxides.c., rotenone (1.5 mg/kg, s.c., 3 times per week), rotenone/L-dopa (25 mg/kg, p.o., daily), rotenone/modafinil (0.1, 0.2 and 0.3 mg/kg respectively, p.o., daily), rotenone/L-dopa/modafinil (0.2 mg/kg, p.o. daily). The treatment was continued for 2 weeks. Mice were tested for behavioral changes 24h after the end of treatments.Mice were evaluated for brain biochemical markers of oxidative stress (lipid peroxidation, reduced glutathione, and nitric oxide), pro-inflammatory factors (tumor necrosis factor-α, interlukin-1beta) and dopamine level. Histopathologic examination and the expression of the anti-apoptotic protein caspase-3 were also performed. Rotenone significantly elevated oxidative stress and pro-inflammation, decreased dopamine, induced substantianigra damage with caspase-3-mediated apoptosis respectly to the control levels. Results of modafinil or its combination with L-dopa may have potential therapeutic effect in Parkinson’s disease by decreasing pro-inflammation and oxidative stress, increasing dopamine, preventing the development of neuronal damage and reducing caspase-3 expression in the striatum.
- 28 April 2019
- Published by Egyptian Knowledge Bank in Egyptian Journal of Chemistry
- Vol. 62 (10) , 1771-1783
Evaluation of Zinc-oxide Nanoparticles effect on treatment of diabetes in streptozotocin-induced diabetic rats
Aim: to produce unique products with novel properties, to manipulate materials at the nano-scale level. Nanoparticles demonstrate novel or improved characteristics which are supported with specific properties such as size and distribution. The effect of zinc oxide nanoparticles (ZnONPs) on diabetic rats induced by streptozotocin- were evaluated in this study. Methods: Forty male albino rats with weight 180-200 gm were used in this study and grouped as follows: Group A: non-diabetic animals (n=10) negative control; Group B1: Diabetic animals that did not received any treatment (n=10) positive control; Group B2: the Diabetic animals (n = 10) who received ZnONPs (10 mg / kg body weight oral daily); Group B3: the Diabetic animals (n=10) who received Diamicron (10 mg / kg body weight oral daily). Intraperitonial injection of streptozotocin by a single dose (60 mg/kg body weight) was used to induce diabetes. After 7 days from the induction, the samples were taken by capillary from fasting rats to measure glucose and insulin (Initial) and after 21 days. At the end of experiment the blood glucose, serum insulin and HbA1c levels were determined for all studied groups. Tissues samples from liver and pancreas were taken to determine the histopathology and gene expression for insulin and insulin receptor. Results: The results indicated high level of blood glucose and low level of insulin in diabetic rats as compared to the -ve control, while their levels were significantly modified in rats that administrated ZnONPs and Diamicron and this results will be confirmed by the gene expression. Conclusion: zinc oxide nanoparticles act as potent antidiabetic agent through decreasing blood glucose and increasing serum insulin.
- 28 April 2019
- Published by Egyptian Knowledge Bank in Egyptian Journal of Chemistry
- Vol. 62 (10) , 1771-1783
Evaluation of Zinc-oxide Nanoparticles effect on treatment of diabetes in streptozotocin-induced diabetic rats
Aim: to produce unique products with novel properties, to manipulate materials at the nano-scale level. Nanoparticles demonstrate novel or improved characteristics which are supported with specific properties such as size and distribution. The effect of zinc oxide nanoparticles (ZnONPs) on diabetic rats induced by streptozotocin- were evaluated in this study. Methods: Forty male albino rats with weight 180-200 gm were used in this study and grouped as follows: Group A: non-diabetic animals (n=10) negative control; Group B1: Diabetic animals that did not received any treatment (n=10) positive control; Group B2: the Diabetic animals (n = 10) who received ZnONPs (10 mg / kg body weight oral daily); Group B3: the Diabetic animals (n=10) who received Diamicron (10 mg / kg body weight oral daily). Intraperitonial injection of streptozotocin by a single dose (60 mg/kg body weight) was used to induce diabetes. After 7 days from the induction, the samples were taken by capillary from fasting rats to measure glucose and insulin (Initial) and after 21 days. At the end of experiment the blood glucose, serum insulin and HbA1c levels were determined for all studied groups. Tissues samples from liver and pancreas were taken to determine the histopathology and gene expression for insulin and insulin receptor. Results: The results indicated high level of blood glucose and low level of insulin in diabetic rats as compared to the -ve control, while their levels were significantly modified in rats that administrated ZnONPs and Diamicron and this results will be confirmed by the gene expression. Conclusion: zinc oxide nanoparticles act as potent antidiabetic agent through decreasing blood glucose and increasing serum insulin.
- Open Access
- 1 December 2018
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 16 (2) , 479-484
Assessment of Ki-67 as a potential biomarker in patients with breast cancer
- 1 December 2018
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 16 (2) , 479-484
Open AccessAssessment of Ki-67 as a potential biomarker in patients with breast cancer
- Open Access
- 23 October 2018
- Published by Springer Nature in Bulletin of the National Research Centre
- Vol. 42 (1) , 14
Evaluation of pro-inflammatory and anti-inflammatory cytokines in type 1 diabetes mellitus
- 23 October 2018
- Published by Springer Nature in Bulletin of the National Research Centre
- Vol. 42 (1) , 14
Open AccessEvaluation of pro-inflammatory and anti-inflammatory cytokines in type 1 diabetes mellitus
- Open Access
- 12 February 2018
- Published by Springer Nature in Egyptian Journal of Medical Human Genetics
- Vol. 19 (3) , 241-246
Association of nonalcoholic fatty liver disease grades with the plasma cell antigen-1 (PC-1) gene polymorphism
- 12 February 2018
- Published by Springer Nature in Egyptian Journal of Medical Human Genetics
- Vol. 19 (3) , 241-246
Open AccessAssociation of nonalcoholic fatty liver disease grades with the plasma cell antigen-1 (PC-1) gene polymorphism
- 1 January 2018
- Published by Clinical Laboratory Publications in Clinical Laboratory
- Vol. 64 (11+12/2018) , 1859-1866
Assessment of Serum Vitamin D and Irisin Levels in Obese Patients
Background: 25-hydroxyvitamin D and irisin have been found to be involved in the pathogenesis of obesity. The aim of the study is to assess the serum levels of 25-hydroxyvitamin D and irisin in obese patients and to determine the association of 25-hydroxyvitamin D and irisin levels with anthropometric parameters. Methods: The study was carried out on 300 obese patients in addition to 156 healthy age and gender matched subjects as a control group. Demographic data were collected from the studied cases. Body mass index, serum levels of insulin, total cholesterol, triglycerides, high-density lipoprotein, low-density lipoprotein, 25-hydroxyvitamin D, and irisin were measured. Results: 25-hydroxyvitamin D levels were significantly associated with obesity, the incidence of 25-hydroxyvitamin D deficiency (< 12 ng/mL) was 49.3% in obese patients, especially in females. A positive correlation was noted between 25-hydroxyvitamin D and age TC:HDL ratio. It was negatively correlated with BMI. Serum irisin levels were higher, but not significantly, in obese patients compared to controls. Irisin was positively associated with insulin levels and negatively correlated with total cholesterol. Conclusions: Obesity is associated with 25-hydroxyvitamin D deficiency and high serum levels of irisin. Body mass index and gender are predictors of 25-hydroxyvitamin D status. The positive correlation between serum irisin and insulin indicates that compensatory enhancement of irisin excretion can occur due to insulin resistance.
- 1 January 2018
- Published by Clinical Laboratory Publications in Clinical Laboratory
- Vol. 64 (11+12/2018) , 1859-1866
Assessment of Serum Vitamin D and Irisin Levels in Obese Patients
Background: 25-hydroxyvitamin D and irisin have been found to be involved in the pathogenesis of obesity. The aim of the study is to assess the serum levels of 25-hydroxyvitamin D and irisin in obese patients and to determine the association of 25-hydroxyvitamin D and irisin levels with anthropometric parameters. Methods: The study was carried out on 300 obese patients in addition to 156 healthy age and gender matched subjects as a control group. Demographic data were collected from the studied cases. Body mass index, serum levels of insulin, total cholesterol, triglycerides, high-density lipoprotein, low-density lipoprotein, 25-hydroxyvitamin D, and irisin were measured. Results: 25-hydroxyvitamin D levels were significantly associated with obesity, the incidence of 25-hydroxyvitamin D deficiency (< 12 ng/mL) was 49.3% in obese patients, especially in females. A positive correlation was noted between 25-hydroxyvitamin D and age TC:HDL ratio. It was negatively correlated with BMI. Serum irisin levels were higher, but not significantly, in obese patients compared to controls. Irisin was positively associated with insulin levels and negatively correlated with total cholesterol. Conclusions: Obesity is associated with 25-hydroxyvitamin D deficiency and high serum levels of irisin. Body mass index and gender are predictors of 25-hydroxyvitamin D status. The positive correlation between serum irisin and insulin indicates that compensatory enhancement of irisin excretion can occur due to insulin resistance.
- Open Access
- 1 October 2017
- Published by Egyptian Knowledge Bank in Egyptian Journal of Chemistry
- Vol. 60 (5) , 3-5
Relationship between Sex Hormone-Binding Globulin (SHBG) and Insulin-Like Growth Factor-I (IGF-I) with Metabolic Syndrome
Background: Glucose intolerance, insulin resistance, hypertension, visceral obesity, and dyslipidemia are the major components of metabolic syndrome (MS). Aim: To evaluate the association between serum SHBG and IGF-1 levels and the risk of MS. Furthermore, to determine the correlations between SHBG and IGF-1 and the main components of MS. Subjects and Methods: A total of 402 subjects with and without MS were enrolled in this study (MS=156, Non-MS=246) aged > 18 years. The age, height, weight, BMI, HC, WC, and incidence of diabetes, hypertension and dyslipidemia of all cases were recorded. The collected serum samples were used to assess lipid profile, glucose and insulin levels. The levels of LDL-cholesterol were calculated using Friedewald’s formula. Insulin resistance was measured (as HOMA score). The levels of serum SHBG and IGF-1 were measured using Elisa technique. Results: A positive relationship between SHBG and MS was detected , however no such correlation was observed concerning IGF-1. There were positive correlations between SHBG and main components of MS; with insulin, HOMA-index, TC, TG and HDL . Conversely, IGF-1showed negative correlations. Finally, SHGB was more sensitive (63.5%), accurate (61.9%) than IGF-1 (51.9%), accuracy (59%) . Conclusion: Our study reveals that lower SHBG is more strongly associated with metabolic syndrome and its main components than lower IGF-1. SHBG could be the essential driver of these relations, conceivably reflecting its association with insulin sensitivity, however, more studies are required to confirm this relationship.
- 1 October 2017
- Published by Egyptian Knowledge Bank in Egyptian Journal of Chemistry
- Vol. 60 (5) , 3-5
Open AccessRelationship between Sex Hormone-Binding Globulin (SHBG) and Insulin-Like Growth Factor-I (IGF-I) with Metabolic Syndrome
Background: Glucose intolerance, insulin resistance, hypertension, visceral obesity, and dyslipidemia are the major components of metabolic syndrome (MS). Aim: To evaluate the association between serum SHBG and IGF-1 levels and the risk of MS. Furthermore, to determine the correlations between SHBG and IGF-1 and the main components of MS. Subjects and Methods: A total of 402 subjects with and without MS were enrolled in this study (MS=156, Non-MS=246) aged > 18 years. The age, height, weight, BMI, HC, WC, and incidence of diabetes, hypertension and dyslipidemia of all cases were recorded. The collected serum samples were used to assess lipid profile, glucose and insulin levels. The levels of LDL-cholesterol were calculated using Friedewald’s formula. Insulin resistance was measured (as HOMA score). The levels of serum SHBG and IGF-1 were measured using Elisa technique. Results: A positive relationship between SHBG and MS was detected , however no such correlation was observed concerning IGF-1. There were positive correlations between SHBG and main components of MS; with insulin, HOMA-index, TC, TG and HDL . Conversely, IGF-1showed negative correlations. Finally, SHGB was more sensitive (63.5%), accurate (61.9%) than IGF-1 (51.9%), accuracy (59%) . Conclusion: Our study reveals that lower SHBG is more strongly associated with metabolic syndrome and its main components than lower IGF-1. SHBG could be the essential driver of these relations, conceivably reflecting its association with insulin sensitivity, however, more studies are required to confirm this relationship.
- 1 October 2017
- Published by Egyptian Knowledge Bank in Egyptian Journal of Chemistry
- Vol. 60 (5) , 6-7
The Combined Effect of ACE, TCF7L2, and PPARGC1A Gene Polymorphisms in Diabetic Nephropathy
Objective: This study was performed for investigation the relationship between variants of ACE, TCF7L2 and PPARGC1A gene polymorphisms individually or in combination with the development of nephropathy in T2DM. Subject and Methods: The study was included 85 T2DM patients (45 with nephropathy and 40 without nephropathy), and 45 healthy control subjects. The I/D polymorphism of ACE gene was evaluated by PCR method. The polymorphisms rs7903146 (C/T) of TCF7L2 gene and Gly482Ser (G/A) and Thr394Thr (G/A) of PPARGC1A gene were evaluated by PCR-RFLP analysis. Results: The frequency of ACE DD genotype and D allele was significantly higher in DN patients when compared to diabetic without nephropathy. The frequency of TCF7L2 rs7903146 TT genotype and T allele were significantly associated with DN patients compared to T2DM. Moreover, a significant association in A allelic frequencies was observed in DN cases compared to T2DM patients without nephropathy. No differences in the genotypic and allelic frequencies between T2DM patients with and without nephropathy were found for the Thr394Thr polymorphism. Conclusions: Our study suggested that candidate gene polymorphisms I/D of ACE, rs7903146 of TCF7L2 and Gly482Ser of PPARGC1A individually or in combination may act as susceptibility biomarkers for nephropathy in T2DM.
- 1 October 2017
- Published by Egyptian Knowledge Bank in Egyptian Journal of Chemistry
- Vol. 60 (5) , 6-7
The Combined Effect of ACE, TCF7L2, and PPARGC1A Gene Polymorphisms in Diabetic Nephropathy
Objective: This study was performed for investigation the relationship between variants of ACE, TCF7L2 and PPARGC1A gene polymorphisms individually or in combination with the development of nephropathy in T2DM. Subject and Methods: The study was included 85 T2DM patients (45 with nephropathy and 40 without nephropathy), and 45 healthy control subjects. The I/D polymorphism of ACE gene was evaluated by PCR method. The polymorphisms rs7903146 (C/T) of TCF7L2 gene and Gly482Ser (G/A) and Thr394Thr (G/A) of PPARGC1A gene were evaluated by PCR-RFLP analysis. Results: The frequency of ACE DD genotype and D allele was significantly higher in DN patients when compared to diabetic without nephropathy. The frequency of TCF7L2 rs7903146 TT genotype and T allele were significantly associated with DN patients compared to T2DM. Moreover, a significant association in A allelic frequencies was observed in DN cases compared to T2DM patients without nephropathy. No differences in the genotypic and allelic frequencies between T2DM patients with and without nephropathy were found for the Thr394Thr polymorphism. Conclusions: Our study suggested that candidate gene polymorphisms I/D of ACE, rs7903146 of TCF7L2 and Gly482Ser of PPARGC1A individually or in combination may act as susceptibility biomarkers for nephropathy in T2DM.